Found: 14
Select item for more details and to access through your institution.
Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1365544
- By:
- Publication type:
- Article
Real‐world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single‐center retrospective study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 5, p. 649, doi. 10.1111/1346-8138.17186
- By:
- Publication type:
- Article
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 261, doi. 10.1007/s40261-024-01352-4
- By:
- Publication type:
- Article
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 519, doi. 10.3390/ph17040519
- By:
- Publication type:
- Article
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 12, p. 1576, doi. 10.1111/1346-8138.16950
- By:
- Publication type:
- Article
Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 3201, doi. 10.2147/CCID.S439053
- By:
- Publication type:
- Article
Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. 1301, doi. 10.1111/1346-8138.16879
- By:
- Publication type:
- Article
Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 7, p. 869, doi. 10.1111/1346-8138.16763
- By:
- Publication type:
- Article
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2201, doi. 10.3390/jcm12062201
- By:
- Publication type:
- Article
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1934, doi. 10.3390/jcm12051934
- By:
- Publication type:
- Article
Galectin-7 and actin are components of amyloid deposit of localized cutaneous amyloidosis.
- Published in:
- Experimental Dermatology, 2013, v. 22, n. 1, p. 36, doi. 10.1111/exd.12065
- By:
- Publication type:
- Article
N<sup>ɛ</sup>-(Carboxymethyl)lysine Modification of Elastin Alters Its Biological Properties: Implications for the Accumulation of Abnormal Elastic Fibers in Actinic Elastosis.
- Published in:
- Journal of Investigative Dermatology, 2012, v. 132, n. 2, p. 315, doi. 10.1038/jid.2011.298
- By:
- Publication type:
- Article
AGE-Modified Collagens I and III Induce Keratinocyte Terminal Differentiation through AGE Receptor CD36: Epidermal–Dermal Interaction in Acquired Perforating Dermatosis.
- Published in:
- Journal of Investigative Dermatology, 2010, v. 130, n. 2, p. 405, doi. 10.1038/jid.2009.269
- By:
- Publication type:
- Article
Cutaneous mucinous nodule in a patient with rheumatoid arthritis.
- Published in:
- Journal of Dermatology, 2008, v. 35, n. 2, p. 98, doi. 10.1111/j.1346-8138.2008.00422.x
- By:
- Publication type:
- Article